Musculoskeletal Pain and Hand Osteoarthritis
Farmalider S.A. sponsors clinical research in erosive osteoarthritis of the hands and erosive/inflammatory osteoarthritis, with a clear emphasis on pain relief, functional discomfort, and symptom control in affected hand joints.
- Hand pain intensity
- Erosive hand osteoarthritis
- Inflammatory joint symptoms
The sponsor’s work in this area is centered on therapies aimed at reducing persistent pain in degenerative and inflammatory joint conditions.
Acute Pain and Postoperative Analgesia
The company supports studies in acute pain and moderate to severe somatic pain, including pain associated with dental procedures and postoperative recovery, reflecting a strong interest in short-term analgesic management.
- Post-surgical pain
- Dental extraction pain
- Somatic pain relief
These trials focus on oral and intravenous analgesic options for rapidly controlling intense pain in clinical settings.
Combination Analgesics and Non-opioid Pain Therapy
Farmalider S.A. has an active research interest in fixed-dose combinations involving ibuprofen, tramadol, and paracetamol, with attention to both efficacy and tolerability in pain treatment.
- Ibuprofen-tramadol combinations
- Paracetamol-ibuprofen formulations
- Analgesic safety
This therapeutic area includes oral suspensions, granules, and other formulations designed for pain control across different clinical contexts.
Healthy Volunteer Studies and Bioavailability
The sponsor also funds research in healthy volunteers to examine formulation characteristics, palatability, and comparative bioavailability of pain-related medicines and other therapeutic agents.
- Formulation comparison
- Oral suspension and granule products
- Single-dose pharmacokinetic assessment
These studies extend to non-pain therapies such as tadalafil, broadening the sponsor’s formulation-focused research portfolio.
